Literature DB >> 23801632

β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.

Deepika Kaveri1, Philippe Kastner, Doulaye Dembélé, Claus Nerlov, Susan Chan, Peggy Kirstetter.   

Abstract

Wnt signaling is important for T-cell differentiation at the early CD4(-)CD8(-) stage and is subsequently downregulated with maturation. To assess the importance of this downregulation, we generated a mouse line (R26-βcat) in which high levels of active β-catenin are maintained throughout T-cell development. Young R26-βcat mice show a differentiation block at the CD4(+)CD8(+) double-positive (DP) stage. These DP cells exhibit impaired apoptosis upon irradiation or dexamethasone treatment. All R26-βcat mice develop T-cell leukemias at 5 to 6 months of age. R26-βcat leukemias remain dependent on β-catenin function but lack Notch pathway activation. They exhibit recurrent secondary genomic rearrangements that lead to Myc overexpression and loss of Pten activity. Because β-catenin activation and Myc translocations were previously found in murine T-cell acute lymphoblastic leukemias (T-ALLs) deficient for Pten, our results suggest that activation of the canonical Wnt pathway is associated with a subtype of Notch-independent T-ALLs that bear Myc gene rearrangements and Pten mutations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23801632     DOI: 10.1182/blood-2012-12-471904

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  The physiological role of Wnt pathway in normal development and cancer.

Authors:  Xiang Li; Maria A Ortiz; Leszek Kotula
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-29

Review 2.  A New View of Pathway-Driven Drug Resistance in Tumor Proliferation.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Trends Pharmacol Sci       Date:  2017-02-27       Impact factor: 14.819

3.  Overcoming Wnt-β-catenin dependent anticancer therapy resistance in leukaemia stem cells.

Authors:  John M Perry; Fang Tao; Anuradha Roy; Tara Lin; Xi C He; Shiyuan Chen; Xiuling Lu; Jacqelyn Nemechek; Linhao Ruan; Xiazhen Yu; Debra Dukes; Andrea Moran; Jennifer Pace; Kealan Schroeder; Meng Zhao; Aparna Venkatraman; Pengxu Qian; Zhenrui Li; Mark Hembree; Ariel Paulson; Zhiquan He; Dong Xu; Thanh-Huyen Tran; Prashant Deshmukh; Chi Thanh Nguyen; Rajeswari M Kasi; Robin Ryan; Melinda Broward; Sheng Ding; Erin Guest; Keith August; Alan S Gamis; Andrew Godwin; G Sitta Sittampalam; Scott J Weir; Linheng Li
Journal:  Nat Cell Biol       Date:  2020-04-20       Impact factor: 28.824

4.  RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.

Authors:  Filip Matthijssens; Nitesh D Sharma; Monique Nysus; Christian K Nickl; Huining Kang; Dominique R Perez; Beatrice Lintermans; Wouter Van Loocke; Juliette Roels; Sofie Peirs; Lisa Demoen; Tim Pieters; Lindy Reunes; Tim Lammens; Barbara De Moerloose; Filip Van Nieuwerburgh; Dieter L Deforce; Laurence C Cheung; Rishi S Kotecha; Martijn Dp Risseeuw; Serge Van Calenbergh; Takeshi Takarada; Yukio Yoneda; Frederik W van Delft; Richard B Lock; Seth D Merkley; Alexandre Chigaev; Larry A Sklar; Charles G Mullighan; Mignon L Loh; Stuart S Winter; Stephen P Hunger; Steven Goossens; Eliseo F Castillo; Wojciech Ornatowski; Pieter Van Vlierberghe; Ksenia Matlawska-Wasowska
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

5.  Arsenic trioxide increases expression of secreted frizzled-related protein 1 gene and inhibits the WNT/β-catenin signaling pathway in Jurkat cells.

Authors:  Yan Wang; Zunsong Wang; Hong Li; Wenwei Xu; Lin Dong; Yan Guo; Saran Feng; Kehong Bi; Chuansheng Zhu
Journal:  Exp Ther Med       Date:  2017-03-06       Impact factor: 2.447

Review 6.  Wnt Signaling in Hematological Malignancies.

Authors:  Stephanie Grainger; David Traver; Karl Willert
Journal:  Prog Mol Biol Transl Sci       Date:  2017-12-29       Impact factor: 3.622

Review 7.  Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.

Authors:  Joseph A Clara; Cecilia Monge; Yingzi Yang; Naoko Takebe
Journal:  Nat Rev Clin Oncol       Date:  2019-12-02       Impact factor: 66.675

8.  Independent and core pathways in oncogenic KRAS signaling.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Expert Rev Proteomics       Date:  2016-07-18       Impact factor: 3.940

9.  Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance.

Authors:  Peter S Choi; Yulin Li; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

10.  β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.

Authors:  C Gekas; T D'Altri; R Aligué; J González; L Espinosa; A Bigas
Journal:  Leukemia       Date:  2016-04-29       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.